Also known as: Azacytidine
Azacitidine is indicated for:
Irrespective of gender only Adults (18 years old or older)
Azacitidine is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:
For this indication, the medical literature mentions below treatments (click for details):
Active ingredient Azacitidine is contraindicated in the following cases:
It is unknown whether azacitidine/metabolites are excreted in human milk.
Due to the potential serious adverse reactions in the nursing child, breast-feeding is contraindicated during azacitidine therapy.